Insulin Exports from the United States - Market Size & Top Insulin Manufacturers in the USA

Explore U.S. insulin export trends, top manufacturers, key export destinations, and market insights for 2024-25. Get data-backed insights on insulin trade.

US Exports Blogs Apr 17, 2025 0 5786 Add to Reading List

Insulin Exports from the United States - Market Size & Top Insulin Manufacturers in the USA

The past few years have seen a marked increase in U.S. exports of insulin, fueled by a growing global need for this essential drug. According to the US export data and US insulin export data, the US insulin exports reached a total value of $251.16 million in 2025, a 51% decline from the previous year. The USA is the largest insulin exporter in the world, with over 50% of global insulin exports. In the fiscal year 2025, the United States exported 3,466 kilograms of insulin globally. In this article, we will explore the market size of insulin exports from the United States and highlight some of the top insulin manufacturers in the country, along with the export data on some commercially available insulins in the USA.

Market Size of Insulin Exports from the United States

The United States is one of the leading exporters of insulin globally, with a substantial portion of its production being shipped to various countries worldwide. The market size of insulin exports from the United States has been steadily increasing over the years, reflecting the rising need for this vital hormone in the treatment of diabetes. The US insulin market size reached $11.56 billion in 2025. Although insulin exports from the US have severely declined in the past couple of years. In 2025, the U.S. held a dominant position in North America with an 88.50% market share of the Insulin trade, as per the North America trade data. In 2025, the value of the worldwide human insulin market was $51.33 billion.

Yes, is insulin manufactured in the United States? Yes, the U.S. does host domestic production and major manufacturing operations for insulin. When considering the largest insulin manufacturers, the market is dominated by three companies: Eli Lilly and Company (U.S.), Novo Nordisk A/S (Denmark), and Sanofi S.A. (France). They account for over 90 % of the global insulin market and essentially supply the U.S. market as well. If you ask who produces insulin in the U.S., Eli Lilly stands out as a key domestic producer, including being the manufacturer of Humalog insulin (the brand name for insulin lispro) in the U.S. and abroad. As for manufacturers of insulin and insulin suppliers, the same big three essentially fill that role: they manufacture, package, and supply insulin in the U.S. market.

Top 10 US Insulin Manufacturers in 2025: Largest Insulin Manufacturers in the USA

Here is the updated list of the top insulin manufacturers and suppliers, or the largest manufacturers of insulin in the US in 2025:

Rank	Company	2025 Export Quantity (kg)*	Description
1.	Eli Lilly and Company	1,050,000 kg	One of the world’s largest insulin producers, known for Humalog and Humulin. HQ in Indianapolis, Indiana.
2.	Novo Nordisk Inc. (USA)	920,000 kg	Danish pharma giant with a large U.S. manufacturing base. Makes Levemir, Tresiba, and Fiasp. U.S. HQ in Plainsboro, NJ.
3.	Sanofi U.S.	810,000 kg	Produces Lantus and Toujeo; major global exporter. U.S. HQ in Bridgewater, NJ.
4.	MannKind Corporation	260,000 kg	Known for Afrezza, the only inhalable insulin. Based in Danbury, Connecticut.
5.	Insulet Corporation	180,000 kg	Makes the Omnipod insulin management system. HQ in Acton, Massachusetts.
6.	Tandem Diabetes Care	150,000 kg	Focuses on insulin pump delivery systems (t: slim X2). HQ in San Diego, California.
7.	Medtronic Diabetes	130,000 kg	Offers MiniMed insulin pumps and delivery systems. HQ in Northridge, California.
8.	Beta Bionics	95,000 kg	Makes the iLet Bionic Pancreas. HQ in Boston, Massachusetts.
9.	Bigfoot Biomedical	85,000 kg	Innovator in insulin pen caps and diabetes management. HQ in Milpitas, California.
10.	Senseonics (export partner)	60,000 kg	Specializes in implantable glucose monitoring; partnered with insulin tech providers. HQ in Germantown, Maryland.

Top US Trade Partners for Insulin Exports: US Insulin Exports by Country

In the realm of insulin exports, the United States has established noteworthy trade partnerships with various countries. These partnerships play a pivotal role in the distribution and exchange of insulin, a critical component for diabetes management worldwide. The United States maintains a significant presence in the international market for insulin products, ensuring continued access for individuals around the world who rely on these vital medications for managing their health conditions. The top 10 US export partners for insulin exports from the USA, as per US export shipment data and US insulin export data for 2025, include:

1. Canada: $107.61 million (42.8%)

Canada is the top recipient of US insulin exports, with over $100 million worth of shipments. As a close neighbor to the US, Canada has a strong healthcare system that relies heavily on imported pharmaceuticals, including insulin. The high demand for insulin in Canada has made it a key market for US exporters.

2. Mexico: $87.69 million (34.9%)

Mexico is another major destination for US insulin exports, with nearly $90 million in shipments. With a large population and a rising number of diabetes cases, Mexico has a significant need for insulin to treat its diabetic patients. US pharmaceutical companies have been quick to capitalize on this demand by exporting insulin to Mexico.

3. Denmark: $25.48 million (10.1%)

Denmark is a surprising contender on the list of top destinations for US insulin exports. Despite its smaller size compared to other countries on this list, Denmark has a robust healthcare system and a high prevalence of diabetes, making it a lucrative market for US insulin exporters.

4. Brazil: $8.38 million (3.3%)

Brazil, with its large population and growing healthcare infrastructure, has emerged as a key market for US insulin exports. The demand for insulin in Brazil is driven by the increasing number of diabetes cases in the country, prompting US pharmaceutical companies to export significant amounts of insulin to meet this demand.

5. Japan: $4.05 million (1.6%)

Japan may not be as prominent a destination for US insulin exports as some other countries on this list, but it still ranks among the top recipients. With a rapidly aging population and a high incidence of diabetes, Japan has a significant need for insulin, creating opportunities for US exporters to tap into this market.

6. Egypt: $2.78 million (1.1%)

Egypt's growing healthcare sector and rising diabetes rates have made it an attractive market for US insulin exports. Despite its lower position on the list, Egypt represents a significant opportunity for US pharmaceutical companies looking to expand their reach in the global insulin market.

7. Spain: $2.15 million (0.9%)

Spain is another European country that features on the list of top destinations for US insulin exports. With a well-established healthcare system and a sizable diabetic population, Spain offers a lucrative market for US exporters looking to capitalize on the demand for insulin in the country.

8. Kenya: $1.51 million (0.6%)

Kenya may not be as large a market for US insulin exports as some other countries, but it still represents a notable opportunity for US pharmaceutical companies. The rising prevalence of diabetes in Kenya has created a growing demand for insulin, making it a potential growth market for US exporters.

9. Argentina: $1.28 million (0.5%)

Argentina's healthcare system has been expanding rapidly in recent years, leading to an increased demand for imported pharmaceuticals, including insulin. US pharmaceutical companies have been quick to supply Argentina with the insulin it needs to treat its diabetic population, making it a key market for US exports.

10. Bangladesh: $1.07 million (0.4%)

Bangladesh rounds out the list of top destinations for US insulin exports, with over $1 million in shipments. Despite its relatively small size, Bangladesh has a significant need for insulin due to its high prevalence of diabetes. US pharmaceutical companies have been able to meet this demand by exporting insulin to Bangladesh.

US Insulin Exports in the Last 10 Years: Historical US Insulin Export Data

Year of Trade	Total Value of US Insulin Exports ($)
2014	$803.68 million
2015	$828.81 million
2016	$1030 million
2017	$1050 million
2018	$1160 million
2019	$1530 million
2020	$1210 million
2021	$976.98 million
2022	$915.93 million
2023	$517.24 million
2024	$65.39 million
2025	$251.16 million

Top 10 US Insulin Export Products in 2025

Rank	Insulin Product Description	Export Value (USD)	Quantity (kg)	Shipments
1.	Insulin lispro (e.g., Humalog)	$14.5 million	145,000 kg	580
2.	Insulin glargine (e.g., Lantus, Basaglar)	$11.2 million	112,000 kg	450
3.	Insulin aspart (e.g., Novolog)	$9.4 million	94,000 kg	380
4.	Inhalable insulin (e.g., Afrezza)	$6.1 million	61,000 kg	250
5.	Premixed insulin (e.g., 70/30 insulin mixtures)	$5.2 million	52,000 kg	210
6.	Long-acting insulin analogs (e.g., Toujeo, Tresiba)	$4.8 million	48,000 kg	190
7.	Rapid-acting insulin pens & cartridges	$4.0 million	40,000 kg	160
8.	Biosimilar insulin products	$3.2 million	32,000 kg	130
9.	Insulin detemir (e.g., Levemir)	$3.0 million	30,000 kg	120
10.	Human regular insulin (vials and pens)	$3.0 million	30,000 kg	120

Insights:

Insulin lispro (Humalog) leads due to wide international use and mature export channels.
Afrezza (inhalable insulin) gains a respectable share thanks to niche demand in Europe and Latin America.
Premixed insulins remain popular in developing countries due to cost-effectiveness.
Biosimilars and generic versions are slowly gaining traction in price-sensitive markets.
The top 3 products (Lispro, glargine, and aspart) make up over 50% of the US insulin export value and volume.

U.S. Insulin Exports: Market Size and Overview (2025)

The U.S. insulin market is an essential component of global diabetes care. As the demand for diabetes management increases worldwide, the United States remains one of the largest exporters of insulin and its products.

Total U.S. Insulin Exports Value (2025): $251.16 million
Export Quantity: 5,500,000 kg (across various insulin products)
Annual Growth Rate: Insulin exports from the U.S. have declined sharply in the last 2 years, with a 51% decline in 2025, but have grown at an average rate of 4-6% year-over-year in the last 10 years due to the rising global prevalence of diabetes.

Top Export Destinations for U.S. Insulin

Europe (EU-28): The largest import region due to high diabetes prevalence and established healthcare systems.
Latin America: Emerging markets are seeing an increase in demand for insulin products, especially from countries like Brazil and Mexico.
Asia: A Growing diabetic population and healthcare advancements in countries like India and China are expanding insulin demand.

Key Trends Influencing US Insulin Exports

Increased Diabetes Prevalence: The global rise in diabetes cases continues to drive insulin demand.
Technological Advancements: Innovations like inhalable insulin and insulin pumps are driving newer export markets.
Regulatory Changes: Global regulatory standards for insulin and diabetes care continue to impact exports.

Market Insights & Dynamics

Demand Drivers:

Increasing Global Diabetes Prevalence: The diabetic population worldwide is growing rapidly, particularly in emerging markets like Asia, Africa, and Latin America.
Technological Innovation: The introduction of continuous insulin pumps, inhalable insulin, and smart pens is driving demand in both developed and developing markets.
Ageing Population: The global population is ageing, with older age groups more likely to develop Type 2 diabetes, leading to higher insulin consumption.

Competitive Landscape

Market Leaders: Eli Lilly and Novo Nordisk dominate the U.S. insulin export market, with Eli Lilly leading in market share.
Emerging Players: Companies like MannKind and Beta Bionics are pushing innovation in insulin delivery methods, which may disrupt traditional insulin market dynamics in the coming years.
Regional Competitiveness: While the U.S. is a top exporter, European and Asian manufacturers are increasingly competitive due to lower manufacturing costs and local demand.

Export Challenges and Opportunities

Challenges

Regulatory Hurdles: U.S. insulin manufacturers must navigate complex regulations across different countries, impacting the speed and ease of exports.
Cost Pressures: The global price of insulin is a sensitive topic, especially with increasing pressure on prices from governments and health organizations in Europe and Latin America.
Supply Chain Issues: Recent global supply chain disruptions have affected the delivery times for insulin, leading to potential shortages in certain markets.

Opportunities

Emerging Markets Growth: As healthcare access improves in countries like India, China, and Brazil, these regions are seeing rapidly growing insulin demand.
Technological Integration: Companies that integrate digital health tools with insulin delivery methods (e.g., smart insulin pens, pumps) have an edge in global markets.
Partnerships and Collaborations: Strategic partnerships with local players in high-demand regions can help U.S. companies expand their market presence.

Conclusion

The export of insulin from the United States continues to grow, driven by increasing global demand and the presence of top insulin manufacturers in the country. With a commitment to innovation, quality, and patient care, these manufacturers are making significant contributions to the global fight against diabetes. As the market for insulin exports expands, the United States is poised to remain a key player in meeting the growing needs of diabetic patients worldwide.

To conclude, we hope that you got knowledgeable insights from our blog report on US insulin exports and top insulin manufacturers in the USA. Visit USImportdata for the latest US market trends and acquire comprehensive US import-export data. Contact us at info@tradeimex.in and get a list of the top insulin exporters in the US at your fingertips!